# Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

> **NCT01616485** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 106 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** TA-1790
- **DRUG:** Sildenafil citrate
- **DRUG:** Placebo
- **DRUG:** Nitrostat

## Key facts

- **NCT ID:** NCT01616485
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01616485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01616485, "Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01616485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*